June 9, 2014
Avion Pharmaceuticals was nominated and awarded a prestigious Healthcare Distribution Management Association (HDMA) 2014 Diana Award for the Best Manufacturer of the Year Award under $300MM. This is a highly valued and esteemed award demonstrating Avion’s professionalism and commitment to the pharmaceutical industry and allegiance to our distributor partners.
For background, The Healthcare Distribution Management Association (HDMA) is the national association representing primary healthcare distributors, the vital link between the nation’s pharmaceutical manufacturer’s and healthcare providers. Each business day, HDMA member companies ensure that 15 million prescription medicines and healthcare products are delivered safely and efficiently to nearly 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDMA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation’s healthcare system.
A commitment to Healthcare, Leadership and Innovation, HDMA’s Distribution Industry Award for Notable Achievement in Healthcare (Diana) has been the industry’s most recognized symbol of excellence since 1959. The award honors pharmaceuticals and consumer product manufacturer members that set the standard of excellence in new product introductions and product promotions as well as build strong business practices with HDMA distributor members.
“We are very proud to receive this important recognition by such an esteemed organization” stated Mike Sullivan, President of Avion Pharmaceuticals. “This notoriety at such an early stage in the company history is quite an achievement.”
Avion CEO Mark Pugh added, “Avion has been very focused and tenacious in striving for industry excellence over the past 2 years and we are proud that the HDMA is a strong partner and grateful for their recognition of our diligent efforts to succeed.”
Avion Pharmaceuticals, LLC., is a Specialty Pharmaceutical company formed to develop and market a portfolio of innovative products in the Women’s Heath and Dermatology therapeutic areas. Avion Pharmaceuticals focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development drugs to fulfill unmet medical needs. For additional information about Avion Pharmaceuticals please contact the company at 678-325-5188.